To the full analysis
Corbion stock: growth
CRBN.ASCorbion reported $1.4B in revenue for fiscal 2025, down 1.6% on the prior year, up 5.1% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−3.3%
per year from 2006 to 2025, per share −2.3%
Earnings (Annual rate)
−1.8%
per year from 2006 to 2025, per share −0.7%
Free cash flow (Annual rate)
2.1%
per year from 2006 to 2025, per share 3.2%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 5.1% | 3.3% | −3.3% |
| Revenue per share | 5.5% | 3.7% | −2.3% |
| Earnings | 0.5% | −0.7% | −1.8% |
| Earnings per share | 0.8% | 0.0% | −0.7% |
| Free cash flow | 30.5% | 6.3% | 2.1% |
| Free cash flow per share | 30.9% | 6.8% | 3.2% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2.68B | $116.02M | $69.26M |
| 2007 | $2.75B | $224.72M | $35.9M |
| 2008 | $2.88B | $99.73M | $38.56M |
| 2009 | $2.83B | $96.18M | $254.31M |
| 2010 | $3.31B | $110.03M | $126.43M |
| 2011 | $3.45B | −$193.14M | $58.51M |
| 2012 | $835.17M | −$72.36M | $159.9M |
| 2013 | $823.98M | $2.44M | −$62.28M |
| 2014 | $853.35M | −$20.28M | −$1.11M |
| 2015 | $1.02B | $88.87M | $55.63M |
| 2016 | $1.01B | $114.8M | $74.35M |
| 2017 | $988.09M | $93.75M | $80M |
| 2018 | $994.19M | $60.17M | $43.66M |
| 2019 | $1.08B | $28.59M | $43.77M |
| 2020 | $1.09B | $81M | $27.15M |
| 2021 | $1.19B | $86.76M | −$135.19M |
| 2022 | $1.62B | $99.73M | −$202.34M |
| 2023 | $1.4B | $80.78M | $17.84M |
| 2024 | $1.43B | $212.98M | $110.7M |
| 2025 | $1.4B | $82.89M | $102.72M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Oct 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.